In-Depth KRAS Biomarker in Lung Cancer | Hope With Answers℠

Discover in-depth information about the KRAS biomarker and lung cancer. Patient advocate Terri Conneran asks Dr. David Carbone from The Ohio State University James Cancer about the KRAS biomarker in lung cancer. KRAS is present in about 25% of lung cancers, but, until recently there have not been effective targeted treatments for this biomarker. Learn what new treatments are currently in trials and expected to be available for patients soon. Get the latest information on tests and treatment possibilities for this biomarker. The Hope With Answers℠ in-depth video series provides the next level of information for patients to understand treatment options, particularly if they've experienced resistance or if their lung cancer has progressed. Start your journey of understanding about lung cancer research today.

Available online, anytime you need it and anywhere you are, Hope With Answers℠ pairs lung cancer patients with leading lung cancer doctors talking about the questions that matter most to lung cancer patients. And, getting the answers from doctors who specialize in lung cancer and dedicate their careers to staying up to date on the best tests, latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients.

The Hope With Answers℠ video series includes videos on biomarker testing, staging in lung cancer, targeted therapies, immunotherapies, thoracic surgery, EGFR biomarker, ALK biomarker, KRAS biomarker, ROS1 biomarker, clinical trials and much more. The videos are designed as stepping stones with the Intro videos discussing the most basic information, followed by the intermediate videos with some deeper knowledge and the in-depth videos providing the most intricate details.